Koji Kitada
Koji Kitada publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Gastric Cancer Management and Outcomes, Inflammatory Biomarkers in Disease Prognosis and Cholangiocarcinoma and Gallbladder Cancer Studies.
- World rank
- #2,322,399 of 7,710,434 ranked researchers
- Rank in Japan
- #45,380 of 383,136
- Works
- 90
- Citations
- 1.4k
- Citations per work
- 15.5
What does Koji Kitada research?
Koji Kitada's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5257.6%
- Medicine5257.6%
- Everything else2831.0%
- Life Sciences1011.4%
- 1Oncology19% of their works
- 2Surgery16% of their works
- 3Pulmonary and Respiratory Medicine15% of their works
- 4Molecular Biology11% of their works
- 5Epidemiology5% of their works
- 6Hepatology3% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Inflammatory Biomarkers in Disease Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Fungal and yeast genetics research
- Gallbladder and Bile Duct Disorders
- Colorectal Cancer Treatments and Studies
- Gastrointestinal Tumor Research and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
Which keywords describe Koji Kitada's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Cholangiocarcinoma, Prognostic Factors, Surgical Management, Endoscopic Resection, Gastric Cancer and Cancer.
- Liver Cancer
- Hepatocellular Carcinoma
- Cetuximab
- Cholecystitis
- Genomics
- Biliary Tract Cancer
- Cancer
- Endoscopic Resection
- Prognostic Factors
- Clinical Practice Guidelines
- Chemotherapy
- Cholangiocarcinoma
- Surgical Management
- Gastric Cancer
- Inflammation
- Intrahepatic Cholangiocarcinoma
- Yeast
- ERCP
- KRAS Mutations
- Imatinib Mesylate
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy202 topics
- Clinical Practice Guidelines192 topics
- Cholangiocarcinoma182 topics
- Prognostic Factors162 topics
- Surgical Management162 topics
- Endoscopic Resection141 topic
- Gastric Cancer141 topic
- Cancer131 topic
- Inflammation131 topic
- Biliary Tract Cancer111 topic
- Intrahepatic Cholangiocarcinoma111 topic
- Genomics91 topic
- Yeast91 topic
- Cholecystitis71 topic
- ERCP71 topic
- Cetuximab61 topic
- KRAS Mutations61 topic
- Hepatocellular Carcinoma51 topic
- Imatinib Mesylate51 topic
- Liver Cancer51 topic
- Sunitinib51 topic
Where does Koji Kitada work?
Koji Kitada's main affiliation in the publication record is Fukuyama Cardiovascular Hospital, Japan.
How many publications and citations does Koji Kitada have?
OpenAlex counts 90 works and 1,393 citations for Koji Kitada, an h-index of 16, ranking #2,322,399 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Koji Kitada
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Koji Kitada. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.